Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2026 Oct 13;20(10):e0014800. doi: 10.1371/journal.pntd.0014800

Travel history and occupation among diagnosed Cutaneous Leishmaniasis cases in Guyana: A multi-site retrospective case series, 2017–2021

Rajini Kurup 1,#, Tiffany Roberts 1,#, Jimmy Naipaul 2,*,#, Zeska Williams 1,‡, Alexus Michael 1,‡, Annastacia Sampson 1,3,‡, Reza Niles-Robin 1,3,‡, Rita Persaud 2,4,5,‡, Abilash Nair 1,‡, Tejroi Naipaul 2,6,‡
Editor: Anil Fastenau7
PMCID: PMC13660906  PMID: 42868149

Abstract

Background

Cutaneous Leishmaniasis (CL) in Guyana has not been systematically characterised in the peer-reviewed literature for several decades. This study aimed to describe the demographic, occupational, geographic, and clinical profile of diagnosed CL cases at Guyana's principal diagnostic sites, and to test, within this case series, whether field-based occupation is associated with reported interior travel and whether travel history is associated with time to presentation.

Methodology/Principal Findings

Retrospective case series (chart review) of CL diagnoses recorded at three facilities in Georgetown and the interior (2017–2021). Of 223 available case records, a random subsample of 170 was abstracted. Occupation and interior travel were patient-declared; their association was tested directly, then via adjusted logistic regression. Most patients (61.8%) reported interior travel, and 45.3% held field-based occupations, chiefly mining and military. Interior travel was more common among field-based than non-field workers (84.4% vs 43.0%; OR = 7.18 [95% CI, 3.42-15.04]; p < .001), and this association persisted after adjustment for age and sex (OR = 7.08 [3.07-16.30]). Younger age was associated with interior travel (OR = 0.96 [0.94-0.98]; p = .001), whereas sex was not. The sample was predominantly male (81.8%; median age 33 years). Patients with interior travel presented earlier than those without (Mdn = 61 vs 243 days; p < .001).

Conclusions/Significance

Most diagnosed CL cases in this series occurred in people reporting interior travel, predominantly those in field-based occupations, and this travel history was associated with earlier presentation. All participants had CL and there was no comparison group, so these findings describe the case population and associations within it rather than risk factors for acquiring infection; they also rest on a single, retrospectively recorded travel variable. They nonetheless indicate where pre-deployment prevention, occupational screening, and traveller advisories could be focused, and they support a case-control study with validated exposure measurement.

Author summary

In Guyana, cutaneous leishmaniasis is a skin disease spread by the bite of infected sandflies, which are found mainly in the forested interior of the country. The records of 170 patients diagnosed with this disease at three health facilities between 2017 and 2021 were reviewed to describe who was affected. Most patients had recently travelled into the interior, and this was especially common among miners and soldiers. Younger patients were more likely to have travelled, and those who had travelled sought care much sooner after their skin sore appeared than those who had not. The study included only people who already had the disease, so it cannot show that travel or a particular job causes infection; it shows how these characteristics are distributed among patients. Even so, these findings can help Guyana's health authorities decide where to focus prevention efforts, such as protective measures for workers heading into the interior and faster diagnosis for anyone returning from such trips with a new skin lesion. They also point to the need for studies that compare people with and without the disease.

Introduction

Leishmaniasis is a vector-borne parasitic disease caused by protozoa of the genus Leishmania, transmitted through the bites of infected female phlebotomine sandflies [1]. Among its clinical manifestations, cutaneous leishmaniasis (CL) is the most prevalent form worldwide, responsible for an estimated 700,000–1,000,000 new cases annually [2,3]. In the Americas, CL is endemic across much of Central and South America, where multiple Leishmania species maintain sylvatic transmission cycles that place forest-exposed individuals at particular risk [4,5].

Guyana presents a distinctive epidemiological context. The country's fewer than 900,000 inhabitants are concentrated along a narrow Atlantic coastal plain [6,7], while the vast interior, encompassing primary tropical rainforest, savannah, and remote hinterland communities, supports artisanal and small-scale gold mining, timber harvesting, and commercial agriculture [8]. These industries generate sustained population movement between comparatively low-exposure coastal environments and high-exposure forested interior settings where phlebotomine sandfly vectors thrive. Guyana's geographic position places it at the intersection of several CL-endemic territories: the interior borders Brazil, a country with one of the highest global CL burdens, while the northwest approaches Venezuela, exposing border communities to epidemiological risk from multiple directions [9].

Studies from neighbouring Brazil, Suriname, and French Guiana have consistently identified gold miners, soldiers, and agricultural workers as the principal high-risk groups for CL acquisition, driven by occupational incursion into forest environments where sandfly vector density is highest [10–17]. More broadly, a systematic review of occupational exposure to leishmaniasis and other vector-borne diseases found soldiers, travellers, migrant workers, miners, and farmers to be the most frequently studied at-risk groups [18]. Yet no systematic, multi-site characterisation of diagnosed CL cases across Guyana's diagnostic infrastructure has been published in the peer-reviewed literature since an isolated outbreak report nearly four decades ago [19]. This gap limits the capacity of public health authorities to identify the populations at greatest risk, design targeted interventions, and allocate resources appropriately within Guyana's national disease control framework.

The present study describes CL cases diagnosed across Guyana's primary diagnostic infrastructure. It had two objectives: (i) to describe the demographic, occupational, geographic, and clinical profile of diagnosed CL cases at Guyana's principal diagnostic sites between 2017 and 2021; and (ii) to test, within this case series, whether field-based occupation is associated with reported interior travel, and whether reported interior travel is associated with time to presentation. It was hypothesised that, among diagnosed cases, patients in field-based occupations would be more likely than those in non-field occupations to report interior travel, and that lesion duration at presentation would differ between travellers and non-travellers. The study includes only people diagnosed with CL and was therefore designed to describe the case population and associations within it, not to estimate the risk of acquiring CL.

Methods

Ethical considerations

Ethical approval was granted by the Ministry of Health, Guyana. All patient records were anonymised prior to abstraction using an institutional Identity Protection Code; no patient identifiers appear in any analytic output, and analysis was conducted on aggregate data only. The study constituted a retrospective analysis of routinely collected clinical and laboratory records involving no direct patient contact or intervention. Procedures were conducted in full accordance with the ethical principles of the Declaration of Helsinki and applicable national regulations governing health research in Guyana.

Study design

This was a retrospective case series based on review of existing clinical and laboratory records covering January 2017 to December 2021, with cross-sectional analysis of the abstracted data; no new data collection or patient contact occurred. All participants had a recorded diagnosis of CL, and no CL-negative comparison group was included. Data were accessed for the purposes of this study between 03/01/2022 and 10/12/2023.

Study setting and population

The study population was patients receiving a recorded clinical diagnosis of cutaneous leishmaniasis at three facilities constituting the primary institutional infrastructure for CL diagnosis in Guyana: (a) a national reference diagnostic centre in Georgetown (Region 4), receiving referred samples and patients from across all ten administrative regions; (b) a regional general hospital serving a major interior mining and forest community in the northwest (Region 1); and (c) a regional general hospital serving a remote southern border community in the Rupununi (Region 9), adjacent to the international boundary with Brazil. Additional CL diagnoses made at a border-area health facility on the Brazilian side of that boundary were captured where clinical records were available and patients were identifiably presenting from Guyanese territory. Diagnosis was made by the attending clinician at each site according to standard local practice; the specific diagnostic method, which may have included microscopy, serology, clinical criteria, or a combination, was not systematically recorded at the individual-patient level and therefore could not be reported. For the purposes of this study, a case was therefore defined as any patient recorded in a participating facility's laboratory register, microscopy report, or case notification form as having a diagnosis of CL during the study period. The term “diagnosed case” is used throughout to reflect this definition.

Not every diagnosed case at these facilities could be included. A total of 223 cases were available for the study; this figure is the number of records that participating facilities were able to locate, retain in intact form, and share, rather than a complete count of all CL diagnoses managed at these sites over the study period. Facility registers indicate that a larger number of cases had been diagnosed than could ultimately be made available, due to gaps in record-keeping, archival condition, and capacity to support retrieval. The 223 cases available for the study should therefore be read as a lower bound on facility caseload rather than a complete enumeration. Inclusion depended on record availability, so the available cases may differ from all diagnosed cases, for example by over-representing facilities or periods with more complete record-keeping. This potential selection bias arose before, and cannot be corrected by, the random subsampling described below.

Clinical and laboratory records at all three facilities are maintained in paper-based archives rather than an electronic medical record system, meaning that data abstraction required manual retrieval and review of each individual case file on-site. Given the absence of dedicated study funding, abstracting all 223 cases in full was not logistically feasible within the resources available to the study team. Rather than abstracting cases on a convenience basis, which would have risked introducing selection bias into which records were reviewed, a random subsample was therefore drawn to determine which case files would undergo abstraction, intended to minimise the risk that the analytic sample would differ systematically from the available case pool despite the constraint on abstraction capacity. A numbered list of these cases was first compiled from the facility registers and logbooks; 170 case numbers were then selected from this list using SPSS's random case selection function, and only the corresponding physical case files were subsequently retrieved from the archives for abstraction. An a priori power analysis for the primary association (field-based occupation by interior travel; χ² test, 1 df, two-sided α = .05) indicated that 170 cases would provide 97.4% power to detect a medium effect (Cohen's w = 0.3), while remaining within the abstraction capacity available. No cases were individually selected for abstraction by the study team. The flow of cases from the available pool to the analytic sample is shown in Fig 1.

Fig 1. Flow of case ascertainment and sampling.

Fig 1

Of the diagnosed CL cases recorded at the participating facilities in 2017–2021, 223 case records could be located, retained in intact form, and shared (a lower bound on facility caseload). A random subsample of 170 was selected for abstraction using SPSS random case selection and formed the analytic sample; the remaining 53 were not abstracted because of limited abstraction capacity. Denominators for variables with incomplete data are given in Table 1.

Data abstraction

For each of the 170 cases retrieved for abstraction, data were drawn from the laboratory registers, microscopy reports, and case notification forms held at the relevant facility. The primary geographic variable abstracted was the administrative region of patient residence at time of diagnosis, assigned according to Guyana's ten administrative region classification and used to describe the geographic distribution of diagnosed cases. Cases with no recorded residential region (n = 2 in the analytic sample) were retained in overall counts but excluded from regional distribution analyses.

Demographic variables abstracted were age (years), sex, and self-reported ethnic group. Both occupation and interior travel history were patient-declared at the time of presentation, rather than inferred or assigned by the research team. Patients themselves reported their occupation, and these statements were recorded by the attending clinician in the free-text clinical record as given. The research team then classified each patient's declared occupation, a priori, as (i) field-based: occupations characterised by sustained or repeated work activity in forested, agricultural, or open-field environments where contact with phlebotomine sandfly vectors is plausible, specifically miners, soldiers, farmers, lumber jacks, loggers, surveyors, ranchers, community health workers, and government natural resource officers; or (ii) non-field: all remaining occupations, the unemployed, students, and those recording no occupation. Patients with no occupation recorded were therefore classified as non-field rather than treated as missing. This classification was based on the nature and setting of the work itself, independent of whether the patient separately reported travelling to the interior; the two variables were captured and analysed separately for this reason. Interior travel history was based entirely on whether the patient described, or did not describe, an excursion into Guyana's interior beyond their registered administrative region of residence; patients who did not describe such travel were coded as non-travellers. Lesion characteristics abstracted included anatomical location, duration prior to presentation (days), and presence of multiple lesions.

Data analysis

Data were analysed using IBM SPSS Statistics (Version 29.0; IBM Corp., Armonk, NY) and Python 3.11. The random subsample of 170 cases was drawn using the SPSS random case selection function. Continuous variables are presented as mean (M) and standard deviation (SD) or median (Mdn) and interquartile range (IQR); categorical variables as count and percentage.

Associations between categorical variables were assessed using chi-squared (χ2) tests or Fisher's exact test; odds ratios (OR) and 95% confidence intervals (CI) were calculated using the Woolf method. The primary association of interest, between field-based occupational category and interior travel, was tested directly using this chi-squared approach prior to regression modelling. Continuous variables were compared between groups using the Mann-Whitney U test.

Binary logistic regression was then performed with interior travel (yes/no) as the criterion variable and field-based occupational category, age (continuous), and sex as predictors, to determine whether this association remained significant after adjustment for age and sex; model fit was evaluated using the overall model chi-square and Nagelkerke R2. Region of residence was examined descriptively rather than entered as a model covariate, both because of its conceptual overlap with facility of presentation and because its ten-plus categories would have strained a model of this sample size.

All hypothesis tests were two-tailed at α = .05. The pre-specified primary analyses were the association between field-based occupation and interior travel (unadjusted and adjusted) and the comparison of lesion duration between travellers and non-travellers. All other comparisons (sex, ethnicity, and region of residence by occupational category or travel status, and comparisons of lesion duration for individual occupational categories against all other patients) were secondary or exploratory. The individual-occupation comparisons of presentation timing were not pre-specified; they were undertaken after the traveller/non-traveller difference in lesion duration was observed.

No correction for multiple comparisons was applied, so secondary and exploratory results are reported as hypothesis-generating, and instances where they would not withstand Bonferroni correction are indicated. Each analysis used all cases with data on the relevant variables (complete-case analysis), and denominators are reported wherever data were missing.

Results

Demographic characteristics of the analytic sample

The analytic sample is described below in turn by demographic and clinical characteristics, geographic distribution, occupational composition, the unadjusted association between interior travel and occupation, the same association after adjustment for age and sex, and an exploratory comparison of presentation timing across occupations. The analytic sample of 170 diagnosed CL cases was predominantly male (n = 139; 81.8%), with a mean age of 35.0 years (SD = 14.5; range = 6–86) and a median age of 33 years (IQR = 23–46). The modal age group was 18–34 years (n = 76; 44.7%); 16 participants (9.4%) were younger than 18 years and 28 (16.5%) were aged 50 years or older. Annual case counts in the analytic sample ranged from 29 (2020) to 44 (2019). Data were complete for age, sex, occupational category, and lesion duration (patients with no occupation recorded being classified as non-field; see Methods). Ethnicity was not recorded for 1 patient (0.6%) and region of residence for 2 (1.2%). Information on multiple lesions was available for 128 of 170 patients (75.3%) and on anatomical location for 120 (70.6%), so these characteristics should be interpreted with the extent of missing data in mind (Table 1).

Table 1. Demographic, occupational, geographic, and clinical characteristics of the analytic sample (n = 170) of diagnosed Cutaneous Leishmaniasis cases across three diagnostic facilities in Guyana, 2017–2021.

Variable n % or M (SD) / Mdn (IQR)
Age (years)
 M (SD) 35.0 (14.5)
 Mdn (IQR) 33 (23–46)
 Range 6–86
 < 18 years 16 9.4
 18–34 years 76 44.7
 35–49 years 50 29.4
 ≥ 50 years 28 16.5
Sex
 Male 139 81.8
 Female 31 18.2
Ethnicity
 Afro-Guyanese 66 38.8
 Mixed Race 40 23.5
 Amerindian 34 20.0
 Indo-Guyanese 29 17.1
 Not recorded 1 0.6
Region of Residence
 Region 4 - Demerara-Mahaica (Georgetown) 55 32.4
 Region 7 - Cuyuni-Mazaruni 37 21.8
 Region 9 - Upper Takutu–Upper Essequibo (Rupununi) 22 12.9
 Region 3 - Essequibo Islands–W. Demerara 13 7.6
 Region 10 - Upper Demerara-Berbice (Linden) 9 5.3
 Region 8 - Potaro-Siparuni 5 2.9
 Regions 1, 2, 5, and 6 combined 27 15.9
 Not recorded 2 1.2
Occupational Category
 Field-based occupations 77 45.3
 Miners 36 46.8†
 Soldiers / military 21 27.3†
 Farmers 9 11.7†
 Loggers, surveyors, and other field 11 14.3†
 Non-field occupations 93 54.7
Interior Travel History
 Travelled to interior region 105 61.8
 No travel documented 65 38.2
Lesion Characteristics
 Duration prior to presentation
 Mdn (IQR), days 90 (31–274)
 Maximum, days 4,380
Multiple lesions (of n = 128 with data) 43 33.6
Anatomical location (of n = 120 with data)
 Lower limb only 81 67.5
 Upper limb only 17 14.2
 Trunk only 6 5.0
 Face / head only 4 3.3
 Generalised 5 4.2
 Multiple sites 7 5.8

Note. M = mean; SD = standard deviation; Mdn = median; IQR = interquartile range. Percentages may not sum to 100 due to rounding. Field-based occupations include miners, soldiers, farmers, lumber jacks, loggers, surveyors, ranchers, community health workers, and government natural resource officers. Lesion location percentages are of those with a documented anatomical site (n = 120). Data on multiple lesions were available for 128 patients; ethnicity was not recorded for 1 patient and region of residence for 2. †Percentage of the field-based occupational subgroup (n = 77), not of the full analytic sample (n = 170).

The ethnic composition of the sample was Afro-Guyanese (n = 66; 38.8%), Mixed Race (n = 40; 23.5%), Amerindian (n = 34; 20.0%), and Indo-Guyanese (n = 29; 17.1%); ethnicity was not recorded for 1 patient (0.6%). Complete sample characteristics are presented in Table 1.

Geographic distribution and travel patterns by region of residence

Cases were distributed across all ten of Guyana's administrative regions (Table 1; Fig 2). Region 4 (Georgetown) contributed the largest number of cases (n = 55), reflecting its role as the most populous region and the site of the national reference centre, while interior Regions 7, 8, and 9 together accounted for 38.1% of cases with a recorded region (64 of 168), compared with approximately 8.4% of the national population (73,866 of 878,674 residents in the 2022 census, the census closest to the study period) [20]. Region 4, by contrast, accounted for 32.7% of cases with a recorded region (55 of 168) but 39.6% of the national population [20]. Reported interior travel differed by region of residence. Travel was reported by 42 of 55 Region 4 residents (76.4%) and 12 of 13 Region 3 residents (92.3%). These rates are consistent with many coastal-resident cases having acquired infection during excursions to the interior rather than through local transmission, though this cannot be confirmed without exposure data beyond self-reported travel history. By contrast, 30 of 64 residents of interior Regions 7, 8, and 9 (46.9%) reported travel, consistent with a greater role for exposure near home.

Fig 2. Diagnosed cutaneous leishmaniasis cases by administrative region of residence, Guyana, 2017–2021.

Fig 2

Regions are shaded by the number of cases among the 168 patients with a recorded region of residence (region not recorded, n = 2). Regions 1, 2, 5, and 6 are shown as a single combined group (n = 27), as in Table 1. The point marks Georgetown. Base layer: Guyana ADM2 (neighbourhood council) boundaries from geoBoundaries (https://www.geoboundaries.org/api/current/gbOpen/GUY/ADM2/; Runfola et al., PLoS ONE 2020;15(4):e0231866), derived from OCHA FISS and DEVInfo LAC data (https://data.humdata.org/dataset/guyana-administrative-level-0-1-and-2-boundaries) and licensed under CC BY 3.0 IGO (https://creativecommons.org/licenses/by/3.0/igo/). Regional boundaries were derived by merging neighbourhood council units. Map produced by the authors in Python using matplotlib.

Occupational composition of the sample

Of the 170 cases, 77 (45.3%) were engaged in field-based occupations. Miners were the most represented group (n = 36; 21.2%), followed by soldiers (n = 21; 12.4%) and farmers (n = 9; 5.3%). All 77 patients in field-based occupations were male, compared with 62 of 93 (66.7%) in non-field categories (Fisher's exact p < .001). In an exploratory comparison, Afro-Guyanese patients were more likely to hold field-based occupations (60.6%) than those in other ethnic groups (range = 32.5–38.2%; χ2(3) = 10.19, p = .017). This comparison was not pre-specified and would not remain significant after Bonferroni correction for the secondary comparisons made, so it should be regarded as descriptive; it may reflect the demographic composition of Guyana's mining and military workforce. The occupational breakdown, including travel rates, sex distribution, and median lesion duration by category, is presented in Table 2.

Table 2. Occupational category, interior travel rate, sex distribution, and lesion duration among the analytic sample (n = 170).

Occupation n % of Sample Travelled to Interior, n (%) Male sex, n (%) Lesion Duration, Mdn, days
Field-based occupations
Miner 36 21.2 33 (91.7) 36 (100) 76
Soldier / military 21 12.4 20 (95.2) 21 (100) 30
Farmer 9 5.3 4 (44.4) 9 (100) 138
Logger / lumber jack 4 2.4 2 (50.0) 4 (100) 42
Other field-based 7 4.1 6 (85.7) 7 (100) 60
Subtotal 77 45.3 65 (84.4) 77 (100) 61
Non-field occupations
No occupation 37 21.8 16 (43.2) 24 (64.9) 304
Student 10 5.9 2 (20.0) 9 (90.0) 91
Self-employed 9 5.3 2 (22.2) 4 (44.4) 274
Labourer 5 2.9 3 (60.0) 5 (100) 213
Housewife / domestic 2 1.2 0 (0) 0 (0) 594
Driver 3 1.8 2 (66.7) 3 (100) 121
Other 27 15.9 15 (55.6) 17 (63.0) 60
Subtotal 93 54.7 40 (43.0) 62 (66.7) 92

Note. Travel = proportion of each occupational group reporting a history of interior travel. Lesion duration values are medians (days); interquartile ranges are omitted here given small cell sizes within several occupational categories and are reported instead at the aggregate traveller/non-traveller level in Table 3. Several occupational categories (e.g., farmer, n = 9; logger/lumber jack, n = 4; driver, n = 3) are too small to support stable estimates and should be interpreted as descriptive rather than as reliable subgroup comparisons; inference at the level of individual occupations is appropriately limited to the larger miner and soldier/military categories. Other field-based category includes surveyors, ranchers, community health workers, GGMC officers, servicemen, and wardens. Subtotal rows in bold.

Interior travel and occupation: Unadjusted association

Of the 170 patients, 105 (61.8%) reported travel to interior or hinterland regions prior to presentation. The most frequently cited destinations were Tacama (n = 15), Marudi (n = 6), Ekereku, Mahdia, New River, Omai, and Blackwater/Bartica (n = 3 each), all hinterland locations in Regions 7–10 associated with mining, military operations, or remote forest settlement.

Field-based occupational category was strongly associated with interior travel: 65 of 77 patients with field-based occupations (84.4%) reported travel, compared with 40 of 93 patients with non-field occupations (43.0%; OR = 7.18 [95% CI, 3.42–15.04]; χ2(1) = 28.85, p < .001). This shows directly, rather than by inference from occupational title alone, that miners and soldiers in this case series reported interior travel at substantially higher rates than other patients. Farmers, by contrast, reported travel at a rate (4 of 9; 44.4%) similar to that of non-field patients. Military personnel showed the highest travel rate within any occupational group (20 of 21; 95.2%), with Tacama the most commonly cited destination. Miners showed a similarly high travel rate (33 of 36; 91.7%). Travellers were significantly younger than non-travellers (M = 32.3 vs 39.4 years; Mann-Whitney U = 2,512, p = .004). Lesion duration was markedly shorter at presentation among travellers (Mdn = 61 days, IQR = 31–92) than among non-travellers (Mdn = 243 days, IQR = 91–731; Mann-Whitney U = 867, p < .001). Key comparisons between travellers and non-travellers are presented in Table 3.

Table 3. Comparison of key characteristics between diagnosed CL patients with and without a history of interior travel (n = 170).

Variable Travellers (n = 105) Non-travellers (n = 65) OR [95% CI] p
Field-based occupation, n (%) 65 (61.9) 12 (18.5) 7.18 [3.42, 15.04] <.001**
Male sex, n (%) 94 (89.5) 45 (69.2) 3.80 [1.68, 8.60] .002**
Age, M (SD), years 32.3 (12.0) 39.4 (16.9) – .004†**
Lesion duration, Mdn (IQR), days 61 (31–92) 243 (91–731) – <.001†**
Region of residence, n (%) <.001‡**
Region 4 (Demerara-Mahaica) 42 (40.0) 13 (20.0) –
Region 3 (Essequibo Islands–W. Demerara) 12 (11.4) 1 (1.5) –
Regions 7, 8, and 9 (interior) 30 (28.6) 34 (52.3) –
Other regions or not recorded 21 (20.0) 17 (26.2) –

Note. OR = odds ratio (Fisher's exact test, Woolf method for 95% CI). †Mann-Whitney U test. OR not applicable (-) for continuous variables. Region percentages are column percentages; ‡χ²(3) test of region distribution by travel status (exploratory; one cell had an expected count of 4.97). ** p < .01.

Patients who did not report interior travel (n = 65) differed from travellers in several respects (Table 3). Just over half (34 of 65; 52.3%) resided in interior Regions 7, 8, or 9, compared with 30 of 105 travellers (28.6%), consistent with a larger share of non-travellers having been exposed near home; a further 13 (20.0%) resided in Region 4. Most non-travellers (53 of 65; 81.5%) held non-field occupations, most commonly no recorded occupation (n = 21), student (n = 8), and self-employed (n = 7), and 20 (30.8%) were female, compared with 11 of 105 travellers (10.5%). Non-travellers were also older and presented after longer lesion durations (Table 3). The records contained no information on peridomestic exposure, housing, or proximity to forest, so the setting in which non-travellers acquired infection could not be determined.

Interior travel and occupation: Adjusted analysis

Binary logistic regression was conducted with interior travel as the criterion and field-based occupational category, age, and sex as predictors (n = 170). The overall model was statistically significant (χ2(3) = 44.98, p < .001; Nagelkerke R2 = .316).

Field-based occupational category was the strongest independent correlate of reported interior travel (B = 1.96, SE = 0.43, Wald χ2 = 21.14, p < .001; OR = 7.08, 95% CI [3.07, 16.30]), with the association holding at a similar magnitude after adjustment for age and sex (OR = 7.08 vs the unadjusted OR = 7.18), indicating that age and sex account for little of the occupation-travel relationship. Younger age was also a significant independent predictor (B = −0.04, SE = 0.01, Wald χ2 = 10.60, p = .001; OR = 0.96, 95% CI [0.94, 0.98]). Male sex did not reach significance after adjustment for occupational category (B = 0.47, Wald χ2 = 1.00, p = .317; OR = 1.61, 95% CI [0.64, 4.06]). Full regression results are presented in Table 4.

Table 4. Binary logistic regression results using interior travel as the criterion variable (n = 170).

Predictor B SE(B) Wald χ² p OR 95% CI [LL, UL]
Intercept 0.83 0.57 2.08 .149 2.29 [0.74, 7.03]
Field-based occupation 1.96** 0.43 21.14 <.001 7.08 [3.07, 16.30]
Age (per year) −0.04** 0.01 10.60 .001 0.96 [0.94, 0.98]
Male sex 0.47 0.47 1.00 .317 1.61 [0.64, 4.06]

Note. Model χ2(3) = 44.98, p < .001; Nagelkerke R2 = .316. B = unstandardized logistic coefficient; SE(B) = standard error; Wald χ2 = Wald chi-square statistic; OR = odds ratio; LL = lower limit; UL = upper limit of 95% confidence interval. ** p < .01.

Exploratory analysis of presentation timing by occupation

Given the magnitude of the travel-related difference in lesion duration, post hoc exploratory comparisons of individual occupational categories against all other patients combined were conducted to assess whether this difference was uniform across field-based occupations. These comparisons were not pre-specified and should be regarded as hypothesis-generating. Soldiers presented with a markedly shorter median lesion duration than the remainder of the sample (Mdn = 31 vs 91 days; Mann-Whitney U = 530.0, p < .001), a difference that would remain significant after Bonferroni correction for the comparisons made. Miners showed no significant difference in presentation timing relative to other patients (Mdn = 76 vs 90 days; Mann-Whitney U = 1283.5, p = .985), despite both groups reporting comparably high travel rates. The remaining occupational categories were too small for meaningful comparison.

Discussion

In this multi-site series of diagnosed CL cases in Guyana, most patients reported interior travel before presentation, and this was especially common among those in field-based occupations. Among cases, field-based occupation was associated with more than sevenfold higher odds of reported interior travel. This pattern is consistent with the economic geography of the country, in which the extractive and defence industries that employ a large portion of the workforce require sustained presence in forested interior environments where phlebotomine sandfly vectors are endemic. The study includes only people with CL, so these findings describe how travel and occupation are distributed within the case population. They do not show that either raises the risk of acquiring infection, which would require comparison with people without CL. The findings also rest heavily on a single, retrospectively abstracted travel variable and should be read with that measurement constraint in mind (see Limitations). Within those limits, they provide the first multi-site description of these characteristics among diagnosed CL cases in Guyana in several decades, and they indicate where stronger, prospectively validated measurement would be most informative.

The geographic distribution across all ten administrative regions, with interior Regions 7, 8, and 9 accounting for over a third of cases but approximately 8% of the national population, is consistent with ongoing transmission in hinterland communities. Transmission intensity was not directly assessed, however, and the pattern may also reflect regional differences in healthcare access, referral, and record availability. A hinterland focus would be consistent with sandfly ecology: vector density is highest in undisturbed and recently disturbed primary forest [21]. At the same time, the high rate of reported travel among Georgetown residents (76.4%) suggests that coastal urban populations are not insulated from CL. Many may encounter it through the same labour pathways and return to the coast as patients. This dual geography matters for surveillance design, as neither a coastal-only nor an interior-only case-finding strategy would capture the full picture.

The concentration of field-based occupations among male patients (all 77 field-based cases were male) is likely to be less a biological finding than a social one. Mining, military service, and commercial forestry in Guyana are overwhelmingly male-dominated sectors, and the sex ratio among cases is consistent with this. The regression result supports this interpretation: once occupational category was accounted for, male sex was not independently associated with interior travel (OR = 1.61; p = .317). Public health messaging framed around sex as a risk characteristic may therefore be misplaced, and occupational role is likely to be a more useful target. As female participation in mining and community health work grows, any fixed assumption that CL is predominantly a male disease risks generating surveillance blind spots.

A clinically important finding is the fourfold difference in lesion duration at presentation between travellers (Mdn = 61 days) and non-travellers (Mdn = 243 days). Among non-travellers, the median delay exceeded eight months, and the maximum was more than twelve years. This places Guyana within the global pattern of late CL presentation in low- and middle-income settings, where poor disease awareness and the painless, slowly progressive nature of lesions delay diagnosis [22,23]. The earlier presentation of travellers invites two non-exclusive interpretations. First, a discrete travel episode may provide a temporal anchor that strengthens the motivation to seek care. Second, patients in formal field-based settings, particularly military personnel and those employed by mining companies with occupational health infrastructure, may be subject to systematic monitoring that identifies lesions before self-presentation. Either mechanism would point towards the value of post-travel and post-deployment health screening as an early case-detection strategy. In exploratory analyses, the early-presentation pattern was concentrated among soldiers rather than miners. This may suggest that military deployment carries a more structured pathway to early detection than the informal occupational health arrangements typical of artisanal mining, but it is a post hoc observation that warrants targeted investigation. Both interpretations should also be weighed against a measurement caveat. Interior travel was abstracted from existing clinical records and may therefore be documented more completely for patients presenting acutely with a recent, salient exposure event. Part of the duration difference could therefore reflect differential ascertainment of travel rather than health-seeking behaviour alone.

Patients who did not report interior travel (38.2% of the series) warrant separate consideration. Just over half lived in interior Regions 7, 8, or 9, which is consistent with infection acquired in or near their home communities rather than during a discrete excursion. Others, including 13 residents of Region 4, may have made short or routine trips that were not recorded, given that travel was noted only when patients described it. Non-travellers were older, more often female, and less often in field-based work than travellers, and they presented after a median of 243 days. They are therefore the group least likely to be reached by occupational health programmes and the most likely to benefit from wider awareness of CL among communities and primary care providers in endemic areas. The records did not capture household or peridomestic exposures, so where and how non-travellers acquired infection remains an open question for the case-control study proposed in the Limitations.

The prominence of Tacama as a travel destination, cited by 15 patients (8.8% of the analytic sample), deserves attention. This single installation accounted for a discrete, identifiable share of cases in this series, consistent with outbreaks among military personnel at forest training sites in French Guiana and Brazil, and with the high cumulative incidence of CL reported across deployed military populations [12,13,24,25]. The available records do not include all CL cases diagnosed nationally, so the contribution of this site to the national burden cannot be estimated from these data. Operationally, a targeted intervention at Tacama (personal protective equipment, insect repellent protocols, post-deployment dermatological screening) could plausibly reduce cases linked to this site; basic pre-deployment prevention measures markedly reduced CL incidence among Peruvian military trainees in the Amazon [26]. Such an intervention would nonetheless require prospective evaluation at Tacama. The major mining destinations (Marudi, Ekereku, Mahdia, Omai) present a harder problem, as exposure there is distributed across numerous independent operators rather than a single chain of command.

The southern border dimension, reflected in Region 9 cases adjacent to Brazil's Roraima state, raises a broader concern about surveillance adequacy in cross-border transmission. Leishmania does not respect international boundaries; movement of miners, agricultural workers, and community members between Lethem and its Brazilian counterparts may generate bidirectional risk that a single-country system cannot fully capture, underscoring the need for binational surveillance.

Implications

These findings carry practical implications, organised around travel, occupation, and cross-border movement. For travel, the marked difference in presentation delay between travellers and non-travellers supports a low-cost measure: a standardised advisory, distributed through clinics and community health workers at coastal departure points, urging anyone returning from interior travel to seek prompt evaluation of any new skin lesion, regardless of occupation. Non-travellers and those in non-field occupations presented far later. They are also less likely to be reached by occupationally targeted programmes, so general public awareness campaigns about CL recognition may carry the greatest marginal benefit for this less visible group.

For occupation, the concentration of cases in field-based work, which was the strongest correlate of reported interior travel in this sample, suggests value in embedding CL prevention within existing occupational health frameworks rather than relying on general population messaging alone. For the Guyana Defence Force, this could include integrating pre-deployment CL education and routine post-deployment dermatological screening into standard protocols for personnel assigned to jungle installations, with Tacama a candidate priority site given the number of cases in this series linked to it. For the mining sector, partnerships between public health authorities, the Guyana Geology and Mines Commission, and mining cooperatives could deliver pre-departure briefings, provide personal protective equipment such as insecticide-treated clothing, and establish routine post-return screening for miners working at interior sites [18]. Agricultural extension services represent a parallel, currently untapped channel for reaching farmers with similar messaging, although farmers were few in this series (n = 9) and their travel patterns resembled those of non-field patients. For cross-border movement, the cases from Region 9 underscore the value of integrated surveillance with Brazil, potentially modelled on existing binational arrangements for other vector-borne diseases along the shared frontier, to capture exposure and case data that neither country's health system can fully see in isolation.

Limitations and future research

The most consequential limitation concerns measurement of the travel variable itself. Interior travel was captured as a binary, self-reported, retrospectively abstracted field with no standardised prompt or recall window, and it structurally under-detects exposure among residents already living in the interior. The central finding rests on this single variable, so its measurement quality is the principal constraint on how much weight the finding can bear; a prospective study using a structured, validated travel-history instrument would substantially strengthen confidence in it. This compounds with a related gap: diagnostic methods were not documented at the individual-patient level, so misclassification with other dermatological conditions cannot be excluded, and non-travellers (who presented with the longest, most ambiguous delays) are plausibly also the group least likely to have received laboratory confirmation, meaning these two sources of uncertainty are not independent.

A further limitation is the absence of a comparison group of CL-negative individuals; because this study describes diagnosed cases alone, the associations reported here characterise correlates of interior travel within the case population rather than risk factors for acquiring CL, which would require a case-control or cohort design. A natural next step would be a facility-based case-control study, comparing diagnosed CL cases with patients attending the same facilities for other conditions, or with community controls from the same regions, using a structured, validated exposure questionnaire covering travel destinations, timing, and duration, occupation, and peridomestic exposures. Parasitological confirmation with species identification (for example, by PCR) in such a study would also reduce diagnostic misclassification. In addition, census data allowed the regional distribution of cases to be compared with the distribution of the population, but no population-level estimate of interior travel or field-based employment in Guyana could be identified. It was therefore not possible to assess whether these characteristics are more common among cases than in the general population; linkage to labour force or mining-registration data would allow such a comparison. Several secondary comparisons were exploratory and not corrected for multiple testing, and some occupational subgroups (for example, farmers, n = 9) were too small for reliable inference. Occupational categories were also grouped by the research team rather than measured directly, introducing a modest further misclassification risk that structured, prospective exposure assessment could resolve. Region of residence was examined descriptively rather than entered into the regression model, for reasons given in Methods, so whether it carries independent predictive value remains untested.

Case ascertainment is a separate concern. The 223 cases available reflect what participating facilities could locate and share, not their full diagnosed caseload, so the true national burden likely exceeds this figure, and the available records may over-represent facilities or periods with more complete record-keeping; the 170-case analytic sample was itself capped by the resources available for manual abstraction from paper-based archives, and the 53 unabstracted cases could not be compared against it on age, sex, or occupation, though random selection was designed to minimise systematic differences. Cross-border case capture from the Brazilian facility could not be independently verified either. These limitations do not alter the descriptive finding that most diagnosed cases in this series reported interior travel, closely linked to field-based occupation, or the association between travel history and earlier presentation; they define the natural next steps for building on these findings.

Conclusion

In this multi-site series, the great majority of diagnosed CL cases in Guyana occurred in people reporting interior travel, predominantly those in field-based occupations, and travellers presented for care substantially earlier than non-travellers. The study includes only diagnosed cases, so these findings describe the case population rather than establishing risk factors for infection. They nonetheless provide the most detailed recent account of who is diagnosed with CL in Guyana. Travel-focused measures, such as post-travel symptom awareness and prompt evaluation of new skin lesions, may help reduce diagnostic delay, complemented by occupational health measures in the military and mining sectors, which reach the groups that most often reported interior travel. A case-control study with validated exposure measurement is now needed to establish which exposures increase the risk of acquiring CL and to show where prevention is needed most.

Data Availability

The data underlying this study contain sensitive patient clinical information and cannot be shared publicly, in accordance with the confidentiality conditions of the ethical approval granted by the Ministry of Health, Guyana. The de-identified dataset is held by the Faculty of Health Sciences, University of Guyana, and is not deposited in a public repository. Requests for access may be submitted to the Faculty of Health Sciences, University of Guyana, Turkeyen Campus, Greater Georgetown, Guyana (email: fhs@uog.edu.gy), and are subject to institutional and ethics approval.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Steverding D. The history of leishmaniasis. Parasit Vectors. 2017;10(1):82. doi: 10.1186/s13071-017-2028-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ruiz-Postigo JA, Jain S, Mikhailov A, Maia-Elkhoury AN, Valadas S, Warusavithana S, et al. Global leishmaniasis surveillance: 2019-2020, a baseline for the 2030 roadmap. Weekly Epidemiol Rec. 2021;96(35):401–19. [Google Scholar]
  • 4.Pan American Health Organization. Leishmaniasis: Epidemiological report of the Americas. 2022.
  • 5.Reis-Cunha J, Reis LC. Human settlement drives population divergence of Leishmania guyanensis at the sylvatic-anthropogenic interface. bioRxiv. 2026. doi: 10.64898/2026.03.06.710114 [DOI] [Google Scholar]
  • 6.Williams P. Regional inequality and development: A study of the coastal-hinterland dichotomy in Guyana. Economic challenges in early 21st century Guyana. Springer Nature Switzerland; 2024. 67–111. doi: 10.1007/978-3-031-75019-9_4 [DOI] [Google Scholar]
  • 7.Armstrong S, Allicock J, Chinnatambi M. Surveying the Socio-Economic Landscape in Guyana. Guyana at a crossroads. Springer Nature Switzerland; 2025. 13–32. doi: 10.1007/978-3-032-02382-7_2 [DOI] [Google Scholar]
  • 8.Naipaul T, Naipaul J, Persaud R, Gangai KN, Naipaul R, Bacchus S. It ain’t just the body that suffering, is the mind too: Occupational health governance and psychological wellbeing among sugarcane workers in Guyana. Cult Psychol. 2026;0(0). [Google Scholar]
  • 9.Rotureau B, Ravel C, Nacher M, Couppié P, Curtet I, Dedet J-P, et al. Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana. J Clin Microbiol. 2006;44(2):468–73. doi: 10.1128/JCM.44.2.468-473.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.de Oliveira Guerra JA, Talhari S, Paes MG, Garrido M, Talhari JM. Clinical and diagnostic aspects of American tegumentary leishmaniosis in soldiers simultaneously exposed to the infection in the Amazon Region. Rev Soc Bras Med Trop. 2003;36(5):587–90. [PubMed] [Google Scholar]
  • 11.Pradinaud R, Moreau B. Cutaneous leishmaniasis in French Guiana: A review of clinical features and therapeutic outcome. Acta Trop. 1996;64(1–2):53–63. doi: 10.1016/S0001-706X(96)00626-3 [DOI] [Google Scholar]
  • 12.Niba Rawlings N, Bailey M, Courtenay O. Leishmaniasis in deployed military populations: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2025;19(3):e0012680. doi: 10.1371/journal.pntd.0012680 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Henry K, Mayet A, Hernandez M, Frechard G, Blanc P-A, Schmitt M, et al. Outbreak of Cutaneous Leishmaniasis among military personnel in French Guiana, 2020: Clinical, phylogenetic, individual and environmental aspects. PLoS Negl Trop Dis. 2021;15(11):e0009938. doi: 10.1371/journal.pntd.0009938 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Loiseau R, Nabet C, Simon S, Ginouves M, Brousse P, Blanchet D, et al. American cutaneous leishmaniasis in French Guiana: An epidemiological update and study of environmental risk factors. Int J Dermatol. 2019;58(11):1323–8. doi: 10.1111/ijd.14625 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Saidi N, Blaizot R, Prévot G, Aoun K, Demar M, Cazenave PA, et al. Clinical and immunological spectra of human cutaneous leishmaniasis in North Africa and French Guiana. Front Immunol. 2023;14:1134020. doi: 10.3389/fimmu.2023.1134020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rotureau B, Joubert M, Clyti E, Djossou F, Carme B. Leishmaniasis among gold miners, French Guiana. Emerg Infect Dis. 2006;12(7):1169–70. doi: 10.3201/eid1207.051466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fouque F, Gaborit P, Issaly J, Carinci R, Gantier J-C, Ravel C, et al. Phlebotomine sand flies (Diptera: Psychodidae) associated with changing patterns in the transmission of the human cutaneous leishmaniasis in French Guiana. Mem Inst Oswaldo Cruz. 2007;102(1):35–40. doi: 10.1590/s0074-02762007000100005 [DOI] [PubMed] [Google Scholar]
  • 18.Msellemu D, Tanner M, Yadav R, Moore SJ. Occupational exposure to malaria, leishmaniasis and arbovirus vectors in endemic regions: A systematic review. Curr Res Parasitol Vector Borne Dis. 2024;6:100185. doi: 10.1016/j.crpvbd.2024.100185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Low-A-Chee RM, Rose P, Ridley DS. An outbreak of cutaneous leishmaniasis in Guyana: Epidemiology, clinical and laboratory aspects. Ann Trop Med Parasitol. 1983;77(3):255–60. doi: 10.1080/00034983.1983.11811706 [DOI] [PubMed] [Google Scholar]
  • 20.Bureau of Statistics Guyana. Preliminary report of the Guyana National Population and Housing Census 2022. Georgetown: Bureau of Statistics Guyana. https://statisticsguyana.gov.gy/census/ [Google Scholar]
  • 21.Rangel EF, Lainson R. Proven and putative vectors of American cutaneous leishmaniasis in Brazil: aspects of their biology and vectorial competence. Mem Inst Oswaldo Cruz. 2009;104(7):937–54. doi: 10.1590/s0074-02762009000700001 [DOI] [PubMed] [Google Scholar]
  • 22.Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392(10151):951–70.doi: 10.1016/S0140-6736(18)31204-2 [DOI] [PubMed] [Google Scholar]
  • 23.Bennis I, Belaid L, De Brouwere V, Filali H, Sahibi H, Boelaert M. “The mosquitoes that destroy your face”. Social impact of Cutaneous Leishmaniasis in South-eastern Morocco, A qualitative study. PLoS One. 2017;12(12):e0189906. doi: 10.1371/journal.pone.0189906 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Dantas-Torres F, Sales KG da S, Miranda DE de O, da Silva FJ, Figueredo LA, de Melo FL, et al. Sand fly population dynamics and cutaneous leishmaniasis among soldiers in an Atlantic forest remnant in northeastern Brazil. PLoS Negl Trop Dis. 2017;11(2):e0005406. doi: 10.1371/journal.pntd.0005406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Brandão-Filho SP, de Brito ME, Martins CA, Sommer IB, Valença HF, Almeida FA, et al. American cutaneous leishmaniasis in a military training center located in Zona da Mata, Pernambuco, Brazil. Rev Soc Bras Med Trop. 1998;31(6):575–8. [PubMed] [Google Scholar]
  • 26.Oré M, Sáenz E, Cabrera R, Sanchez JF, De Los Santos MB, Lucas CM, et al. Outbreak of cutaneous leishmaniasis in peruvian military personnel undertaking training activities in the Amazon Basin, 2010. Am J Trop Med Hyg. 2015;93(2):340–6. doi: 10.4269/ajtmh.15-0107 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0014800.r001

Decision Letter 0

Claudia Brodskyn, Anil Fastenau

22 Sep 2026

Response to Reviewers Revised Manuscript with Track Changes Manuscript

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Journal Requirements:

1) We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see

https://journals.plos.org/plosntds/s/data-availability#loc-unacceptable-data-access-restrictions

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Reviewers' comments:

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: 1. They tell you what they're studying, but never write out a clean, testable hypothesis. You have to infer it.

2. Appropriate for a descriptive/associative aim, but not for the causal or "risk factor" framing the paper sometimes uses (abstract: "risk pathway"; Discussion: "occupation raised the odds"). This is a case-only cross-sectional review, there is no CL-negative comparison group, so nothing here establishes risk of acquiring CL, only correlates of travel history within confirmed cases. The authors do acknowledge this in Limitations, which is good, but the language elsewhere in the abstract/discussion should be tightened to avoid implying risk-factor inference the design can't support.

3. Reasonably well described, but two soft spots: (a) "confirmed case" isn't rigorously defined since they didn't record how each diagnosis was made, and (b) the 223 cases are just whatever records the facilities happened to still have (not all diagnosed cases) so there's selection bias baked in before their random subsampling even starts

4. The main analysis (170 patients) is big enough. But they just assert a power calculation without showing the numbers behind it. Also, some occupation subgroups (like farmers, n=9) are way too small to draw real conclusions from, which the authors partly admit.

5. Broadly yes and appropriately matched to data type. However, no correction for multiple comparisons across the numerous subgroup tests (ethnicity × occupation, individual-occupation-vs-rest duration comparisons, per-region travel rates). Calling the occupation-timing analysis "exploratory" partially addresses this, but the ethnicity–occupation χ² and some other tests are presented without that caveat and read as confirmatory.

Reviewer #2: The aim (lines in Introduction, final paragraph; repeated in the Abstract Background) is stated as a descriptive purpose rather than a testable hypothesis. More importantly, the aim as written — to establish “whether the disease burden is disproportionately concentrated among travellers” — is not answerable by this design (see 2). I would suggest restating the objectives as two explicit, design-matched questions, e.g.: (i) to describe the demographic, occupational, geographic and clinical profile of diagnosed CL cases at Guyana’s principal diagnostic sites, 2017–2021; and (ii) to test, within this case series, whether field-based occupation is associated with reported interior travel and with time to presentation. Both are well supported by the data.

This is a case-only series: every participant has CL. Without a comparison group, and without an external estimate of how common interior travel and field-based work are in the Guyanese population, the proportion of cases reporting travel (61.8%) cannot establish that burden is “concentrated” among travellers, nor that travel is the “proximate exposure”. What the data do support is a description of the case population and an internal association between occupation and travel among cases. The authors state this clearly and fairly in Limitations (paragraph 2) — the problem is that the title, Abstract Conclusions, Discussion opening sentence (“Cutaneous leishmaniasis in Guyana is, at its core, a travel-associated disease burden”), and the Conclusion (“reframes cutaneous leishmaniasis in Guyana as a disease structured primarily by interior travel”) all assert the causal reading that the Limitations section disclaims. I would ask the authors to bring the whole manuscript into line with the Limitations paragraph. Concretely: retitle along the lines of “Travel history and occupation among diagnosed cutaneous leishmaniasis cases in Guyana: a multi-site retrospective series, 2017–2021”, and rephrase the claim to something like “the great majority of diagnosed cases occurred in people reporting interior travel, predominantly in field-based occupations”. If any national or regional estimate of interior travel prevalence exists (census, labour force survey, GGMC registration data), even a rough comparison would materially strengthen the “concentration” argument and would be worth adding.

Reviewer #3: Yes

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: 1. Mostly yes. They said they'd do χ²/Fisher's exact first, then adjusted logistic regression, then look at duration, and that's the order the Results follow. One thing that sneaks in unannounced: the soldier-vs-miner presentation-timing breakdown is introduced as "exploratory" in the Results with no mention in Methods that this comparison was planned.

2. Largely yes (numbers, CIs, and p-values are given consistently, and Tables 1-4 back up the text). A few gaps: they never report how many patients had missing occupation or ethnicity data (they do this for region, lesion location, and multiple lesions, but not everywhere). Also the geographic-travel-by-region numbers (76.4% Region 4, 92.3% Region 3, 46.9% interior) might be worth pulling into Table 1 or its own table since they're used to support a Discussion claim.

3. Tables are decent: well-labeled, footnoted where cell sizes are small. One issue: there's no actual figure, no map of case distribution by region, no flowchart of case ascertainment (223 → 170 → analytic sample), which would help a reader follow the sampling logic a lot faster than the prose does.

Reviewer #2: (No Response)

Reviewer #3: Yes

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: 1. Mostly, yes, with one recurring overreach. The data do support "interior travel is common and strongly tied to field-based work, and travellers present sooner." But the paper keeps sliding into risk-factor language ("occupation raised the odds," "risk pathway") when all they actually have is an association among existing cases, no comparison to people without CL.

2. Yes very clearly, no comment.

3. Somewhat. They don't say much about what specific next study would close the gap (e.g., a case-control design, a validated travel-history tool), beyond a general "future research should" nod in the limitations.

4. Yes, this is well done.

Reviewer #2: (No Response)

Reviewer #3: Yes

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: The manuscript is generally clear and easy to follow, but I have a few minor suggestions that could improve clarity.

Some of the wording in the Discussion could be a little more cautious. For example, the statement that the geographic distribution “speaks to transmission intensity in hinterland communities rather than mere healthcare access patterns” feels too strong, as transmission intensity was not directly assessed. Similarly, referring to Tacama’s contribution to the “national CL burden” may be an overstatement given that the available cases do not represent all CL cases diagnosed nationally.

It would also help to make the missing clinical data a bit more visible. For example, information on multiple lesions was available for 128 of 170 patients and anatomical location for 120 of 170. Although these denominators are reported in Table 1, briefly mentioning the extent of missing data in the Results would make these findings easier to interpret.

Finally, some parts of the Discussion contain quite long sentences with several interpretations and recommendations combined. Breaking these up, particularly in the sections on presentation delay and occupational exposure, would improve readability.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This study provides useful descriptive data on cutaneous leishmaniasis in Guyana, where recent epidemiological evidence is limited. The multi-site approach and assessment of both interior travel and occupation are strengths. The main weakness is the retrospective, case-only design, which limits the conclusions to associations within confirmed CL cases and does not support broader risk-factor inference. Overall, the study is relevant and well presented, but some conclusions should be more cautiously framed to reflect these limitations.

Reviewer #2: (No Response)

Reviewer #3: It is an interesting report on cutaneous leishmaniasis situation in Guyana. There is a good data on travel transmission of the disease within the country. But a consistent part of the analysed patients did not travel. We have no epidemiologic informations on these patients. The authors could detail the epidemiology of non-travellers patients

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes:  Mourad MOKNI

Figure resubmission

Reproducibility: -->To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols-->?>

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0014800.r003

Decision Letter 1

Claudia Brodskyn, Anil Fastenau

27 Sep 2026

Dear Dr Naipaul,

We are pleased to inform you that your manuscript 'Travel History and Occupation Among Diagnosed Cutaneous Leishmaniasis Cases in Guyana: A Multi-Site Retrospective Case Series, 2017–2021' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Claudia Ida Brodskyn

Section Editor

PLOS Neglected Tropical Diseases

Claudia Brodskyn

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0014800.r004

Acceptance letter

Claudia Brodskyn, Anil Fastenau

Dear Dr Naipaul,

We are delighted to inform you that your manuscript, "Travel History and Occupation Among Diagnosed Cutaneous Leishmaniasis Cases in Guyana: A Multi-Site Retrospective Case Series, 2017–2021," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    pntd.0014800.s002.docx (27.3KB, docx)

    Data Availability Statement

    The data underlying this study contain sensitive patient clinical information and cannot be shared publicly, in accordance with the confidentiality conditions of the ethical approval granted by the Ministry of Health, Guyana. The de-identified dataset is held by the Faculty of Health Sciences, University of Guyana, and is not deposited in a public repository. Requests for access may be submitted to the Faculty of Health Sciences, University of Guyana, Turkeyen Campus, Greater Georgetown, Guyana (email: fhs@uog.edu.gy), and are subject to institutional and ethics approval.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES